Thompson Siegel & Walmsley Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AerCap
AER
|
+$58.9M |
| 2 |
Antero Resources
AR
|
+$58.9M |
| 3 |
Casey's General Stores
CASY
|
+$56M |
| 4 |
Range Resources
RRC
|
+$54.5M |
| 5 |
Ally Financial
ALLY
|
+$49.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$64.4M |
| 2 |
LVNTA
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
|
+$46.1M |
| 3 |
Bio-Rad Laboratories Class A
BIO
|
+$39.6M |
| 4 |
ECHO
EchoStar
ECHO
|
+$35.6M |
| 5 |
CMS Energy
CMS
|
+$32.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.86% |
| 2 | Technology | 12.57% |
| 3 | Consumer Discretionary | 10.42% |
| 4 | Utilities | 9.91% |
| 5 | Healthcare | 8.78% |
Similar funds
Thompson Siegel & Walmsley's Q1 2017 Portfolio in Review
As of Q1 2017, Thompson Siegel & Walmsley held 1,013 positions worth $8.51B, up 12% from $7.63B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Thompson Siegel & Walmsley deployed $656M of net new capital in Q1 2017, opening 120 new positions and adding to 249 existing holdings. Its largest new stake was AerCap: 1,315,670 shares worth $60.5M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Teva Pharmaceuticals, an estimated $64.4M trimmed.
- Thompson Siegel & Walmsley's largest Q1 2017 buy was AerCap: 1,315,670 shares worth $60.5M.
- Thompson Siegel & Walmsley added most to Antero Resources in Q1 2017, an estimated $58.9M increase.
- Thompson Siegel & Walmsley's biggest Q1 2017 reduction was Teva Pharmaceuticals, cutting an estimated $64.4M.
- Thompson Siegel & Walmsley fully exited TXNM Energy Inc in Q1 2017, selling an estimated $19M.
- Thompson Siegel & Walmsley's ten largest holdings make up 15% of its $8.51B portfolio in Q1 2017.
- Thompson Siegel & Walmsley opened 120 new positions and closed 154 in Q1 2017.
- Thompson Siegel & Walmsley's portfolio value rose 12% quarter-over-quarter to $8.51B.
Based on Thompson Siegel & Walmsley's 13F filing for Q1 2017, filed 15 May 2017.